Fri, November 11, 2016
Thu, November 10, 2016

Salveen Richter Initiated (ACAD) at Hold and Held Target at $28 on, Nov 11th, 2016

Salveen Richter of Goldman Sachs, Initiated "ACADIA Pharmaceuticals Inc." (ACAD) at Hold and Held Target at $28 on, Nov 11th, 2016.

Salveen has made no other calls on ACAD in the last 4 months.



There is 1 other peer that has a rating on ACAD. Out of the 1 peers that are also analyzing ACAD, 0 agree with Salveen's Rating of Hold.



This is the rating of the analyst that currently disagrees with Salveen


  • Tazeen Ahmad of "B of A Securities" Upgraded from Hold to Strong Buy on, Tuesday, November 8th, 2016